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Fat metabolism and glucose homeostasis are processes that are highly interconnected. Cao et 
al. (2008) now take this concept a step further by identifying a fatty acid metabolite generated in 
adipose tissue that regulates insulin sensitivity in liver and muscle.Fatty acid metabolism is now appreci-
ated as an important contributor to the 
pathogenesis of insulin resistance and 
type 2 diabetes (Savage et al., 2007). 
This concept harkens back to the pio-
neering work of McGarry and colleagues 
(McGarry, 1992), who posed that dia-
betes mellitus might primarily be a dis-
ease of lipid metabolism rather than of 
glucose metabolism. Although abnormal 
glucose homeostasis and hyperglycemia 
remain the clinical hallmarks of diabetes 
mellitus, elevated levels or increased 
flux of free fatty acids also typify states 
of insulin resistance in both man and 
animals. Free fatty acids in the circula-
tion are taken up by muscle and liver, 
where they are stored as triglycerides or 
metabolized through the mitochondrial 
beta-oxidation pathway (Figure 1). When 
this system becomes unbalanced, such 
that mitochondrial oxidation cannot keep 
pace with the accumulation of intracellu-
lar fatty acyl-CoA, a variety of fatty acid 
metabolites build up within insulin target 
cells. For example, palmitic acid leads to 
the generation of intermediary metabo-
lites such as long-chain fatty acyl-CoA, 
diacylglycerol, and ceramide. In addition, 
palmitate exerts proinflammatory effects 
on macrophages, Kupffer cells, and 914 Cell 134, September 19, 2008 ©2008 Eother cell types (Stratford et al., 2004; 
Postic and Girard, 2008; Schenk et al., 
2008), and all of these effects have been 
reported to cause insulin resistance. 
However, not all fatty acids are the same: 
polyunsaturated fatty acids have little or 
no effect on insulin signaling, and omega 
three fatty acids might actually improve 
insulin sensitivity. In this issue, Cao et al. 
(2008) report a new link between fatty 
acid metabolism and insulin resistance. 
Their findings show that palmitoleate, a 
free fatty acid made by adipocytes, is a 
circulating factor that modulates insulin 
sensitivity in liver and muscle.
This new mechanism of regulating 
insulin sensitivity involves specific fatty 
acid-binding proteins (FABPs). FABPs 
are lipid chaperones that bind to intra-
cellular fatty acids, coupling them to 
signaling pathways or conveying them 
to their ultimate cellular destination. In 
their current work, Cao et al. used an 
unbiased lipodomics analysis, mea-
suring more than 400 lipid species in 
blood and tissue samples. As expected, 
major changes in a large number of 
lipid classes are observed in tissues 
and blood of wild-type animals fed a 
diet of normal chow compared to mice 
fed a high-fat diet. Mice lacking FABP4 lsevier Inc.and FABP5 in adipose tissue are rela-
tively protected from these dramatic 
changes in lipid profiles. Previous work 
has shown that mice deficient in both 
FABP4 and FABP5 display a remark-
able state of insulin sensitivity and are 
protected from metabolic deterioration 
induced by a high-fat diet (Maeda et al., 
2005). In addition, treatment of obese 
mice with a small-molecule inhibitor of 
FABP4 causes a variety of beneficial 
effects, including improvement in glu-
cose tolerance and amelioration of sys-
temic insulin resistance (Furuhashi et 
al., 2007).
Cao et al. next sought to determine 
whether there might be a specific lipid 
signal that tracks with insulin sensitivity 
and identified palmitoleate as a fatty acid 
that is highly enriched in the adipose tis-
sue of mice deficient in both FABP4 and 
FABP5. A high-fat diet caused a marked 
decrease in the concentration of palmi-
toleate in adipose tissue in wild-type ani-
mals, whereas only a minimal decrease 
was observed in the FABP-deficient 
mice. They also observed a 4-fold higher 
concentration of palmitoleate in plasma 
of FABP-deficient mice, compared 
to wild-type mice on high-fat diets. 
Because dietary levels of palmitoleate 
are very low, the source of 
this unique fatty acid is de 
novo synthesis in adipose tis-
sue, indicating that adipocyte 
FABPs regulate this biosyn-
thetic pathway.
To demonstrate the exis-
tence of a communication link 
from adipose tissue, Cao et 
al. identified potential mecha-
nisms whereby palmitoleate 
could signal an increase in 
insulin sensitivity to muscle 
and liver. Using in vitro and 
in vivo reporter systems, 
they found that palmitoleate 
decreases activation of the 
SCD-1 promoter, whereas 
palmitate has the opposite 
effect. SCD-1 is the desatu-
rase that converts palmitate to 
palmitoleate. Hence, this find-
ing reveals an enzyme/prod-
uct negative feedback system 
in which palmitoleate derived 
from adipose tissue inhibits 
expression of SCD-1 in the 
liver. This results in decreased 
de novo hepatic lipogenesis, 
decreased steatosis (excess 
fat deposition in the liver), 
and improved hepatic insulin 
action in the FABP-deficient 
mice. With respect to the 
muscle, they also provide evi-
dence that palmitoleate treat-
ment of a mouse muscle cell 
line (C2C12 cells) leads to an 
improvement in insulin sig-
naling. This is consistent with 
previous reports indicating 
similar effects of palmitoleate 
on insulin action in vitro (Dimo-
poulos et al., 2006) and in vivo (Matsuzaka 
et al., 2007). They also show that palmi-
toleate exerts anti-inflammatory effects 
in adipocytes. Finally, they administered 
lipid infusions to mice of triglyceride (TG) 
emulsions in which the glycerol-bound 
fatty acids were either palmitoleate (TG 
palmitoleate) or palmitate (TG palmitate) 
and found that TG palmitate inhibited the 
early steps in insulin signaling in both liver 
and muscle and caused in vivo insulin 
resistance. In contrast, TG palmitoleate 
potentiated the early steps in insulin sig-
naling and led to an increase in systemic 
insulin sensitivity.
From these studies, the view emerges 
that in wild-type animals, a high-fat 
diet suppresses de novo synthesis of 
fatty acids in adipose tissue, leading to 
decreased production of palmitoleate, 
which contributes to insulin resistance. 
In the absence of the lipid chaperones 
(as in the FABP double-knockout mice), 
a high-fat diet does not suppress fatty 
acid synthesis, and circulating palmi-
toleate levels remain high, preserving 
insulin sensitivity. In this way, circulating 
palmitoleate, which the authors term a 
lipokine, serves as both a biomarker for 
de novo fatty acid synthesis and as an 
adipocyte-derived signaling 
molecule that can influence 
insulin sensitivity in muscle 
and liver (Figure 1).
The authors have devel-
oped an important new story 
that highlights the interaction 
between nutritional inputs and 
tissue-specific adaptations, 
providing a new mechanism 
for intertissue communication 
through adipocyte-derived 
palmitoleate. As in any com-
plex system, many ques-
tions remain unanswered. The 
FABPs are clearly integral to 
this entire mechanism and 
are necessary for the effect 
of nutritional fat overload to 
suppress de novo lipogene-
sis. In the absence of FABPs, 
palmitoleate can no longer 
suppress SCD-1, raising the 
question as to how FABPs 
accomplish this task. The lipid 
chaperone must in some way, 
directly or indirectly, shuttle 
palmitoleate to the nucleus, 
where it exerts transcriptional 
control over the SCD-1 gene 
in the liver. Although palmi-
toleate causes insulin sensiti-
zation in muscle, the SCD-1-
based mechanism would not 
apply in this tissue. Thus, it 
is unclear how this fatty acid 
favorably interacts with the 
early steps of insulin action.
Perhaps the major unan-
swered question is how 
these findings will trans-
late into man. Earlier stud-
ies have indicated that the 
capacity of human adipocytes for de 
novo biosynthesis of fatty acids is con-
siderably less than in rodent models. 
If this is the case, then one has to be 
sure that the biosynthetic capacity of 
human adipose tissue is sufficient to 
cause meaningful swings in circulat-
ing palmitoleate levels under different 
nutritional or disease conditions. Are 
circulating palmitoleate levels higher 
in insulin-sensitive individuals than in 
those who are insulin resistant? Does 
treatment with thiazolidinediones, which 
enhance insulin sensitivity, increase 
palmitoleate levels? It will be important 
figure 1. Metabolic Pathways for fatty Acid Metabolism
Fatty acids are taken up into cells through a series of fatty acid transport pro-
teins and are rapidly acylated after uptake. Fatty acyl-CoAs can then undergo 
beta oxidation within the mitochondria or can be stored after conversion to 
monoglycerides, diglycerides, and then triglycerides. Excessive fatty CoAs 
derived from palmitic acid can be converted to ceramide, diacylglyceride, and 
fatty acyl-CoAs, which have all been reported to cause decreased insulin sig-
naling. In liver and adipose tissue, fatty acyl-CoAs can be produced through 
de novo biosynthesis through a series of progressive enzymatic steps involv-
ing acetyl-CoA carboxylase (ACC), fatty acid synthetase (FAS), and stearoyl-
CoA desaturase (SCD). After acylation, incoming free fatty acids bind to fatty 
acid-binding proteins, and FABP4 and FABP5 are the dominant forms ex-
pressed in adipocytes. FABP4 and FABP5 can shuttle the fatty acyl-CoAs to 
their proper intracellular location, where they can initiate regulatory effects. 
In the nucleus, the desaturated fatty acid, palmitoleate (C16:1n7) inhibits 
expression of biosynthetic pathway genes. Within adipocytes, triglyceride 
stores undergo lipolysis, and the fatty acids are released into the circulation. 
Palmitoleate is mainly derived from de novo fatty acid synthesis, and when 
adipocyte triglycerides containing this fatty acid are hydrolyzed, palmitoleate 
is released into the circulation and can promote insulin sensitivity, whereas 
saturated fatty acids promote insulin resistance. GPAT, glycerol-3-phosphate 
acyltransferase; AGPAT, acylglycerolphosphate acyltransferase; DGAT, dia-
cylglycerol acyltransferase; HSL, hormone-sensitive lipase.Cell 134, September 19, 2008 ©2008 Elsevier Inc. 915
to follow developments as the answers 
to some of these questions emerge. 
In the meantime, given that macada-
mia nuts are the richest known source 
of dietary palmitoleate, perhaps we 
should indulge while we wait.
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The faithful segregation and inheritance 
of genetic material is a hallmark of living 
cells. In eukaryotic cells, chromosome 
segregation is accomplished by the 
largely conserved mechanism of mito-
sis whereby specific DNA sequences 
(centromeres) are recognized by a pro-
tein complex called the kinetochore and 
are driven toward opposite ends of the 
cell by a spindle apparatus. Bacteria, in 
contrast, seem to use a variety of strat-
egies to achieve chromosome segrega-
tion. As a consequence, the challenge 
of elucidating the multiple mechanisms 
used by bacteria to ensure that each 
daughter cell faithfully inherits a copy of 
the genetic material has been daunting. 
In the aquatic bacterium Caulobacter 
crescentus, chromosome segregation 
occurs by a harpoon-like mechanism 
in which the newly duplicated origins of 
replication of the chromosome become 
anchored at the extreme opposite 
poles of the cell. How this anchoring 
is accomplished has been a mystery. 
In this issue, Bowman et al. and Eber-
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sbach et al. report the discovery of a 
protein (PopZ) that forms a Velcro-like 
surface at the cell poles. PopZ enables 
chromosome anchoring by grasping 
onto ParB proteins, which are clustered 
on the chromosome near the site at 
which DNA replication is initiated.
The mechanisms of chromosome seg-
regation differ among bacterial species, 
but two features of the segregation pro-
cess seem to be common to all bacteria 
yet distinct from chromosome segrega-
tion in eukaryotes. First, chromosome 
segregation commences during replica-
tion rather than after its completion. Sec-
ond, chromosome segregation is medi-
ated from sites (often ill-defined) located 
near the origin of replication. As a con-
sequence, chromosome segregation 
can, and often does, commence shortly 
after the initiation of replication. What 
happens next, however, differs markedly 
from species to species.
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mences with the origin located in the 
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S.A. (2004). J. Biol. Chem. 279, 36608–36615.central region of the cell. In B. subtilis, 
the newly duplicated origin regions move 
apart toward opposite ends of the cell 
and are found at the outer edges of the 
two masses of daughter DNA molecules 
known as nucleoids (Figure 1A; Lewis and 
Errington, 1997; Lin et al., 1997; Webb et 
al., 1997). In E. coli, the origins also move 
apart but become located in the center 
of the daughter nucleoids as replication 
proceeds (Figure 1A; Reyes-Lamothe et 
al., 2008). A strikingly different situation 
is found in Caulobacter and Vibrio chol-
erae (V. cholerae actually contains two 
chromosomes but for simplicity we only 
consider the larger one). In both bacteria, 
replication begins with the origin located 
near one pole of the cell. Next, one of the 
two newly duplicated origin regions is pro-
pelled like a harpoon all the way across 
the cell where it becomes anchored at the 
extreme opposite pole (Figure 1B; Fogel 
and Waldor, 2006; Viollier et al., 2004).
The two new studies by Bowman et 
al. (2008) and Ebersbach et al. (2008) 
now demonstrate how this anchoring 
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